ErVimmune | $19,917,795 | (Jan 21, 2026)
Statusphere | $18,000,000 | (Jan 21, 2026)
Think Bioscience | $55,000,000 | (Jan 21, 2026)
Certified by Founder
Lodge
Encord
start up
United States
- San Francisco, California
- 14/08/2024
- Series B
- $30,000,000
Encord is the leading data development platform for advanced vision and multimodal AI teams. We build tools and infrastructure to help our clients get their models into production faster with a data-centric model testing and evaluation framework, human-centric workflow and annotation tools for labeling & RLHF, and data curation and management software.
Encord is trusted by pioneering AI teams at Stanford Medicine, Mass General Brigham, Tractable, Viz AI, Iterative Health, the UHN, the Royal Navy, Veo, and many more global companies.
- Industry Software Development
- Website https://encord.com/
- LinkedIn https://www.linkedin.com/company/encord-team/
POINT.LAZ | $3,000,000 | (Jan 21, 2026)
Jetson(CANADA) | $50,000,000 | (Jan 21, 2026)
BrightInsight | $13,000,000 | (Jan 21, 2026)
Formulary Financial | $4,600,000 | (Jan 21, 2026)
Ultra Pouches | $11,000,000 | (Jan 21, 2026)
XBuild | $19,000,000 | (Jan 21, 2026)
Dam Secure | $4,000,000 | (Jan 21, 2026)
Infinitopes | $15,400,000 | (Jan 21, 2026)
Cosmos | $15,000,000 | (Jan 21, 2026)